The new P2Y12 inhibitor cangrelor unreliably inhibits heparin-induced platelet aggregation in the presence of HIT antibodies, an in vitro study

被引：0
|
作者：
Scala, E. [1 ]
Gerschheimer, C. [2 ,3 ]
Gomez, F. J. [2 ,3 ]
Alberio, L. [2 ,3 ,4 ]
Marcucci, C. [1 ,4 ]
机构：
[1] Lausanne Univ Hosp CHUV, Dept Anesthesiol, Lausanne, Switzerland
[2] Lausanne Univ Hosp CHUV, Div Hematol, Lausanne, Switzerland
[3] Lausanne Univ Hosp CHUV, Cent Hematol Lab, Lausanne, Switzerland
[4] Univ Lausanne UNIL, Fac Biol & Med, Lausanne, Switzerland
来源：
SWISS MEDICAL WEEKLY | 2019年
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FC 19
引用
收藏
页码：8S / 8S
页数：1
相关论文
共 50 条
  • [41] Patients with congenital abnormality of platelet aggregation induced by Ca2+ ionophores may have a defect of the platelet P2Y12 receptor for ADP
    Cattaneo, M
    Lecchi, A
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 115 (02) : 485 - 486
  • [42] Nucleoside triphosphates inhibit ADP, collagen, and epinephrine-induced platelet aggregation: Role of P2Y1 and P2Y12 receptors.
    Aslam, Muhammad
    Sedding, Daniel
    Koshty, Ahmed
    Santoso, Santot
    Schulz, Rainer
    Hamm, Christian
    Guenduez, Dursun
    THROMBOSIS RESEARCH, 2013, 132 (05) : 548 - 557
  • [43] Purinergic P2Y12 receptor blockade inhibits shear-induced platelet phosphatidylinositol 3-kinase activation
    Reséndiz, JC
    Feng, SJ
    Ji, GL
    Francis, KA
    Berndt, MC
    Kroll, MH
    MOLECULAR PHARMACOLOGY, 2003, 63 (03) : 639 - 645
  • [44] Patients with congenital abnormality of platelet aggregation induced by Ca2+ ionophores may have a defect of the platelet P2Y12 receptor for ADP -: Reply
    Fuse, I
    Higuchi, W
    Uesugi, Y
    Aizawa, Y
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 115 (02) : 487 - 487
  • [45] RETRACTED: Antiangiogenic Effect of Platelet P2Y12 Inhibitor in Ischemia-Induced Angiogenesis in Mice Hindlimb (Retracted Article)
    Wang, Xiaoli
    Zhao, Huan
    Yang, Naiquan
    Jin, Yue
    Chen, Jianguo
    BIOMED RESEARCH INTERNATIONAL, 2021, 2021
  • [46] Ticagrelor binds to human P2Y12 independently from ADP but antagonizes ADP-induced receptor signaling and platelet aggregation
    van Giezen, J. J. J.
    Nilsson, L.
    Berntsson, P.
    Wissing, B. -M.
    Giordanetto, F.
    Tomlinson, W.
    Greasley, P. J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (09) : 1556 - 1565
  • [47] The reversible oral P2Y12 antagonist AZD6140 inhibits ADP-induced contractions in mouse aorta in addition to established inhibitory effects on platelet aggregation
    Svensson, Helen
    Erlinge, David
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (06) : E136 - E136
  • [48] Reversal of the platelet inhibitory effect of the P2Y12 inhibitors clopidogrel, prasugrel, and ticagrelor in vitro: a new approach to an old issue
    Schoener, Lisa
    Jellinghaus, Stefanie
    Richter, Bernhardt
    Pfluecke, Christian
    Ende, Georg
    Christoph, Marian
    Quick, Silvio
    Loehn, Tobias
    Speiser, Uwe
    Poitz, David M.
    Mierke, Johannes
    Strasser, Ruth H.
    Ibrahim, Karim
    CLINICAL RESEARCH IN CARDIOLOGY, 2017, 106 (11) : 868 - 874
  • [49] Reversal of the platelet inhibitory effect of the P2Y12 inhibitors clopidogrel, prasugrel, and ticagrelor in vitro: a new approach to an old issue
    Lisa Schoener
    Stefanie Jellinghaus
    Bernhardt Richter
    Christian Pfluecke
    Georg Ende
    Marian Christoph
    Silvio Quick
    Tobias Loehn
    Uwe Speiser
    David M. Poitz
    Johannes Mierke
    Ruth H. Strasser
    Karim Ibrahim
    Clinical Research in Cardiology, 2017, 106 : 868 - 874
  • [50] Comparison of a New P2Y12 Receptor Specific Platelet Aggregation Test with Other Laboratory Methods in Stroke Patients on Clopidogrel Monotherapy
    Bagoly, Zsuzsa
    Sarkady, Ferenc
    Magyar, Tuende
    Kappelmayer, Janos
    Pongracz, Endre
    Csiba, Laszlo
    Muszbek, Laszlo
    PLOS ONE, 2013, 8 (07):
12345